Product Dossier
CEPROTIN
Product Dossier for CEPROTIN (Protein C, Takeda Pharmaceuticals). ARTG record, PBS listing, PBAC outcomes — compiled by arcimedes.
- Sponsor: Takeda Pharmaceuticals
- Active ingredient: Protein C
- Therapeutic area: Haematology
- Related brand: BERIPLEX
- Same area: REVOLADE
- Same area: NOVICRIT
What it is
CEPROTIN is a protein C product available as a powder for injection in two strengths: 500 IU and 1000 IU, each supplied with a diluent vial.
Regulatory history
CEPROTIN was first registered on the ARTG on 30 June 2005, with both the 500 IU and 1000 IU presentations registered simultaneously under licence category RE. ---
*Note: The provided source document contains limited information. A complete Brand Dossier typically requires additional clinical and regulatory documentation including approved indications, dosing recommendations, safety warnings, contraindications, PBS listing details, and full regulatory history. These details are not available in the current source.*